Added to YB: 2022-10-03
Pitch date: 2022-10-03
TARO [bullish]
Taro Pharmaceutical Industries Ltd.
+39.38%
current return
Author Info
No bio for this author
Company Info
Taro Pharmaceutical Industries Ltd. develops, manufactures, and supplies prescription and over-the-counter pharmaceutical products, including active pharmaceutical ingredients and finished dosage forms.
Market Cap
$1.6B
Pitch Price
$30.83
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.23
P/E
29.98
EV/Sales
0.44
Sector
Pharmaceuticals
Category
value
Taro Pharmaceuticals: A Profitable Net-Net
TARO: Profitable net-net at $29. $1.18B cash/no debt vs $1.13B mkt cap = business valued at -$50M while earning ~$100M/yr ($3/share). 10x P/E ex-cash. Generic pharma post-price-fixing crackdown ($419M settlement), margins stabilizing >50%. Sun Pharma owns 80% (takeover risk/upside). Buying below $29 for aggressive portfolio.
Read full article (6 min)